Skip to content
★ Sign in to follow
解

解江冰

Cadre supérieur
爱博医疗
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€138k
▼ Sales (0 ops.)
—

Latest filing published 26 Aug 2024 for 爱博医疗, €74k.

Filing timeline

BuySale
解江冰

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2
Positive at T+90
50%
Median T+90
+7.9%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 26 Aug 2024 · 804 days ago · €74k
    +3.5%
    Entry CN¥73.50 · Close at T+365 CN¥76.05
  • Filed 25 Jun 2024 · 866 days ago · €64k
    -10.5%
    Entry CN¥77.10 · Close at T+365 CN¥69.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

解江冰: trading record in brief

解江冰 (senior executive) discloses dealings in 爱博医疗 to SSE / SZSE (CSRC). Over a trading history stretching from 25 June 2024 to 26 August 2024, the count stands at 2 filings.

No open-market sale appears; the market trades are 2 purchases worth €138k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

The latest filing, published on 26 August 2024, reports an open-market purchase of €74k in 爱博医疗. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.

Companies and markets linked to 解江冰

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    董事,高级管理人员,核心技术人员Executives爱博医疗
    590,990 CNY24SSE
    8,008 shares53.8% of flowA股XSHGSSE:173000008014222100
    Canonical exit: 24 Nov 2024 (T+90)
  • ▲
    董事,高级管理人员,核心技术人员Executives爱博医疗
    497,488 CNY12SSE
    6,800 shares46.2% of flowA股XSHGSSE:173000007783241540
    Canonical exit: 23 Sept 2024 (T+90)

2 of 2 declarations